These markers are involved in tumor proliferation (Ki-67), cell cycle control (cyclin D1), genomic instability (P53), and immune evasion (PD-L1), and their expression may be partially driven by the underlying differentiation program of the tumor. Here, TP53 is linked to neoplasm.